These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 23938173

  • 1. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
    Lohr JB, Liu L, Caligiuri MP, Kash TP, May TA, Murphy JD, Ancoli-Israel S.
    Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y, Takasaki Y, Yamashiro Y.
    J Clin Sleep Med; 2013 Aug 15; 9(8):751-7. PubMed ID: 23946704
    [Abstract] [Full Text] [Related]

  • 3. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 15; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    Pierre JM, Peloian JH, Wirshing DA, Wirshing WC, Marder SR.
    J Clin Psychiatry; 2007 May 15; 68(5):705-10. PubMed ID: 17503979
    [Abstract] [Full Text] [Related]

  • 5. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, Yee BJ, Grunstein RR, Marshall NS.
    Thorax; 2014 Mar 15; 69(3):274-9. PubMed ID: 24287166
    [Abstract] [Full Text] [Related]

  • 6. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y, Miki M, Tabata T.
    Sleep Med; 2016 Mar 15; 27-28():45-48. PubMed ID: 27938918
    [Abstract] [Full Text] [Related]

  • 7. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM, D'Souza DC, Patkar AA, Youakim JM, Tiller JM, Yang R, Keefe RS.
    J Clin Psychiatry; 2010 Nov 15; 71(11):1475-81. PubMed ID: 20816042
    [Abstract] [Full Text] [Related]

  • 8. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 9. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug 15; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan 15; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 11. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
    Bobo WV, Woodward ND, Sim MY, Jayathilake K, Meltzer HY.
    Schizophr Res; 2011 Aug 15; 130(1-3):106-13. PubMed ID: 21641776
    [Abstract] [Full Text] [Related]

  • 12. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 15; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 13. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.
    Sleep Med; 2013 Oct 15; 14(10):955-63. PubMed ID: 23920422
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.
    Kane JM, Yang R, Youakim JM.
    Schizophr Res; 2012 Mar 15; 135(1-3):116-22. PubMed ID: 22178084
    [Abstract] [Full Text] [Related]

  • 15. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V, Miodownik C, Gibel A, Sirota P, Bush I, Elliot H, Benatov R, Ritsner MS.
    J Clin Psychiatry; 2013 Dec 15; 74(12):1224-32. PubMed ID: 24434091
    [Abstract] [Full Text] [Related]

  • 16. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR, Modafinil in Depression Study Group.
    J Clin Psychiatry; 2003 Sep 15; 64(9):1057-64. PubMed ID: 14628981
    [Abstract] [Full Text] [Related]

  • 17. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S, Rosenthal MH, Alvir J, Meyer S, Visweswaraiah H, Gunduz-Bruce H, Schooler NR.
    J Clin Psychiatry; 2005 Jul 15; 66(7):839-43. PubMed ID: 16013898
    [Abstract] [Full Text] [Related]

  • 18. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.
    J Affect Disord; 2009 May 15; 115(1-2):18-26. PubMed ID: 19230981
    [Abstract] [Full Text] [Related]

  • 19. Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
    Loebel AD, Siu CO, Cucchiaro JB, Pikalov AA, Harvey PD.
    CNS Spectr; 2014 Apr 15; 19(2):197-205. PubMed ID: 24330860
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
    Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R.
    Neuropsychopharmacology; 2008 May 15; 33(6):1217-28. PubMed ID: 17625502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.